ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1033

Reliability and Responsiveness of Two Methods for Assessment of Magnetic Resonance Imaging Abnormalities in Hip Osteoarthritis in a Placebo-Controlled Trial of Intra-Articular Steroid Injection

Walter P. Maksymowych1, Jolanda Cibere2, Ulrich Weber3, Jacob Jaremko4, Damien Loeuille5, Veronika Zubler6, Frank Roemer7, Eric C. Sayre8 and Robert GW Lambert4, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Div of Rheumatology, Arthritis Research Ctr of CA, Vancouver, BC, Canada, 3Rheumatology, Balgrist University Hospital, Zurich, Switzerland, 4Radiology, University of Alberta, Edmonton, AB, Canada, 5Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France, 6Radiology, Balgrist University Hospital, Zurich, Switzerland, 7Klinikum Augsburg, Augsburg, Germany, 8Arthritis Research Centre of Canada, Vancouver, BC, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: magnetic resonance imaging (MRI) and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Inflammation in osteoarthritis (OA) is the basis for the use of steroid injection therapy which has demonstrated efficacy for symptoms of hip OA in a randomized placebo-controlled trial1. Both synovitis and bone marrow lesions (BML) have been associated with pain in OA and can be detected on MRI. Two scoring methods have been developed which assess synovitis-effusion but score BML using different approaches: 1) the Hip Inflammation MRI Scoring System (HIMRISS) assesses BML using consecutive images in the coronal plane and a dichotomous (yes/no) scoring method; 2) the Hip Osteoarthritis MRI Scoring System (HOAMS) is a whole joint scoring system which assesses BML according to volume of region affected on both coronal and sagittal scans.  We aimed to determine the reliability and responsiveness of both methods for detecting change in these MRI lesions and associations with clinical changes in patients receiving steroid injection therapy.

Methods:  Six readers (3 radiologists, 3 rheumatologists) assessed MRI scans of hip joints from 18 patients enrolled into a randomized double-blinded placebo-controlled trial of intra-articular steroid treatment for hip OA.  Scans were performed at baseline and the primary endpoint at 8 weeks.  Coronal STIR sequences of the hip joints were evaluated. For HIMRISS, the sum of femoral BML scores (0-65), acetabular BML scores (0-35), effusion score (0-30) and total score was calculated based on femoral and acetabular subregion readings. In HOAMS, BML (0-3) and synovitis (0-2), were assessed in femoral and acetabular subregions and summed scores for all subregions were calculated for BML (0-45) and synovitis (0-8). Reliability of change scores was assessed using intra-class correlation coefficient (ICC), responsiveness by standardized response mean (SRM) and Guyatt’s effect size (ES). We assessed associations with WOMAC pain subscale in the same patients and a second cohort of 27 patients with early OA by regression analysis.

Results:  Inter-observer reliability of change scores was very good to excellent for femoral BML, and good to very good for synovitis-effusion and acetabular BML despite limited training. Reliability was comparable between radiologists and rheumatologists. Responsiveness and discrimination was moderate to high for synovitis-effusion. Significant associations were noted between BML or synovitis scores and pain scores for baseline values (p ≤ 0.001 in combined N=45) but not change values (N=18). The association with pain was particularly evident in patients with early OA (N=27) with the HIMRISS synovitis-effusion (p = 0.001) and HOAMS synovitis (p = 0.005) scores.

 

ICC (change)

ICC (Rheumatologist)

ICC (Radiologist)

SRM

Guyatt’s ES

Total HIMRISS

Femoral BML HIMRISS

Acetabular BML HIMRISS

Synovitis-effusion HIMRISS

0.77

0.81

0.49

0.35

0.76

0.80

0.52

0.48

0.82

0.82

0.54

0.36

0.16

0.03

0.14

0.55

0.33

0.08

0.19

0.69

HOAMS BML

HOAMS Synovitis

0.71

0.58

0.73

0.58

0.71

0.69

0.18

0.44

0.29

0.95

Conclusion: Change in BML and synovitis on MRI is reliably detected using both HOAMS and HIMRISS but only synovitis scores are responsive to treatment. Association with pain is primarily evident in early OA and with scores for synovitis-effusion.

  1. Lambert et al. Arthritis Rheum 2007; 56: 2278

Disclosure:

W. P. Maksymowych,
None;

J. Cibere,
None;

U. Weber,
None;

J. Jaremko,
None;

D. Loeuille,
None;

V. Zubler,
None;

F. Roemer,
None;

E. C. Sayre,
None;

R. G. Lambert,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-and-responsiveness-of-two-methods-for-assessment-of-magnetic-resonance-imaging-abnormalities-in-hip-osteoarthritis-in-a-placebo-controlled-trial-of-intra-articular-steroid-injection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology